For research use only. Not for therapeutic Use.
Anti-KAAG1 (ADCT-901-MMAE) is an ADC composed of a humanized monoclonal antibody (3A4) targeting human KAAG1. It is used for the treatment of advanced solid tumors including platinum resistant ovarian cancer and triple negative breast cancer. MW :145.28 KD.
| Catalog Number | I047080 |
| Purity | ≥95% |
| Reference | [1] https://www.adctherapeutics.com/our-pipeline1-1/adct-901/ |
